WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

South Korea · Delayed Price · Currency is KRW

7,400.00

-500.00 (-6.33%)

At close: Sep 11, 2026

KOSDAQ:330350 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	111,719	106,444	102,722	80,119	64,680	57,419
Revenue Growth	9.00%	3.62%	28.21%	23.87%	12.65%	7.51%
Gross Profit	71,893	68,830	65,554	48,638	38,335	33,525
Operating Income	4,074	5,663	5,661	7,909	4,878	4,886
Net Income	7,964	4,967	4,785	7,959	2,479	4,264
Earnings Per Share	603.28	376.31	362.00	603.00	188.00	323.00
EPS Growth	33.32%	3.95%	-39.97%	220.75%	-41.80%	-59.83%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	20,874	19,440	18,893	11,192	26,556	42,478
Total Debt	18,563	18,724	24,065	20,001	21,467	23,105
Net Cash (Debt)	2,311	716.07	-5,172	-8,809	5,089	19,373
Net Cash Growth	850.80%	-	-	-	-73.73%	-12.80%
Net Cash Per Share	175.08	54.25	-391.26	-667.36	385.93	1467.59

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	8,805	6,781	9,630	-1,237	5,380	8,021
Capital Expenditures	-5,017	-1,298	-2,362	-10,807	-15,332	-6,667
Free Cash Flow	3,788	5,483	7,268	-12,044	-9,952	1,354
Free Cash Flow Growth	-69.94%	-24.56%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.35%	64.66%	63.82%	60.71%	59.27%	58.39%
Operating Margin	3.65%	5.32%	5.51%	9.87%	7.54%	8.51%
Pretax Margin	3.80%	4.24%	5.00%	11.41%	6.43%	9.13%
Profit Margin	7.13%	4.67%	4.66%	9.93%	3.83%	7.43%
FCF Margin	3.39%	5.15%	7.07%	-15.03%	-15.39%	2.36%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.27	22.91	19.43	16.13	49.86	32.48
P/FCF Ratio	25.79	20.76	12.79	-	-	102.25
PS Ratio	0.87	1.07	0.91	1.60	1.91	2.41